ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 279,41
0,62%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Bausch plus Lomb Corporation (BLCO)

  7. Bausch plus Lomb Corporation (BLCO) Actualités

BLCO Bausch plus Lomb Corporation

13,26
-0,60 (-4,33%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Bausch plus Lomb Corporation BLCO NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,60 -4,33% 13,26 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
14,04 13,53 14,35 13,60 13,86
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202412:58BWBausch + Lomb Announces First-Quarter 2024 Results
29/4/202413:00BWBausch + Lomb Announces Presentation of New Data at the..
25/4/202414:30BWBausch + Lomb Announces Statistically Significant Results..
18/4/202413:00BWBausch + Lomb Reports More Than 84 Million Units of Contact..
15/4/202418:00BWBausch + Lomb Will Release First-Quarter 2024 Financial..
27/3/202412:00BWBausch + Lomb Will Present New Scientific Data and Analyses..
04/3/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202414:12EDGAR2Form 8-K - Current report
28/2/202414:00BWBausch + Lomb Announces Appointment of Karen L. Ling to..
21/2/202413:00EDGAR2Form 8-K - Current report
21/2/202413:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
21/2/202412:58BWBausch + Lomb Announces Fourth-Quarter and Full-Year 2023..
05/2/202418:00BWBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023..
08/1/202412:59BWBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser..
03/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:00BWBausch + Lomb to Participate in the 42nd Annual J.P. Morgan..
15/11/202312:59BWBausch + Lomb Reports More Than 76 Million Units of Contact..
13/11/202322:47EDGAR2Form 8-K/A - Current report: [Amend]
07/11/202323:00EDGAR2Form 8-K/A - Current report: [Amend]
01/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202312:02EDGAR2Form 8-K - Current report
01/11/202311:58BWBausch + Lomb Announces Third-Quarter 2023 Results and..
26/10/202312:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
16/10/202318:00BWBausch + Lomb Will Release Third-Quarter 2023 Financial..
04/10/202312:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
03/10/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:24EDGAR2Form 8-K - Current report
29/9/202316:00BWBausch + Lomb Completes Acquisition of XIIDRA®
26/9/202312:59BWBausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the..
20/9/202312:59BWBausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling..
14/9/202323:26EDGAR2Form 8-K - Current report
14/9/202323:25BWBausch + Lomb Announces Pricing of Senior Secured Notes..
12/9/202312:59BWBausch + Lomb Launches MIEBO™ (Perfluorohexyloctane..
11/9/202313:22EDGAR2Form 8-K - Current report
11/9/202313:07BWBausch + Lomb Announces Launch of Proposed Financing for..
06/9/202323:58BWBausch + Lomb Announces Disclosure of Historical and Pro..
06/9/202323:28EDGAR2Form 8-K - Current report
06/9/202312:59BWBausch + Lomb Will Present New Scientific Data on its..
29/8/202323:05EDGAR2Form 8-K/A - Current report: [Amend]
29/8/202313:00BWBausch + Lomb Will Participate at the 2023 Wells Fargo..
24/8/202313:00BWBausch + Lomb Announces Expiration of Hart-Scott-Rodino..
02/8/202323:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/8/202323:09EDGAR2Form S-3ASR - Automatic shelf registration statement of..
02/8/202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NYSE
BLCO
Bausch plus Lomb
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés